ARCHIVES

FDA Delays Decision On Avastin Approval For Breast Cancer

This article is from The Cancer Letter archive.

Vol. 36 No. 34 | September 24, 2010

Download PDF Visit The Full Archive

Related Articles

GAO Eppley Report Offers Lessons for Grantees, Contractors

March 3, 1978

Cancer Death Rates Declined 2.1 Percent Per Year.

October 19, 2007

Contract Authority Expiration Confuses NCI Money Bill Estimates, Which Range From $605 To $650 Million

June 21, 1974

Funding Opportunities: RFA Available: Teams For Molecular Target Assessment

November 26, 1999

NCI Stops Trial Of Screening In Men To Add Women

November 2, 1990

Survival Benefit For Vinorelbine-Cisplatin In NSCLC Patient, Phase III Trial Finds

August 26, 2005